Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 13.2B | 14.7B | 13.0B | 12.7B |
Cost of revenue | 6.8B | 8.1B | 7.8B | 7.2B |
Gross profit | 6.5B | 6.6B | 5.2B | 5.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.4B | 2.6B | 2.3B | 2.3B |
Operating income | 2.8B | 2.8B | 1.8B | 2.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 152.5M | 149.8M | 127M | 135.2M |
Other income expense | — | — | — | — |
Pretax income | 2.9B | 3.0B | 1.9B | 2.2B |
Tax provision | 741.2M | 735M | 467.2M | 583.9M |
Net income | 2.2B | 2.2B | 1.5B | 1.6B |
Basic EPS | 3.5 | — | 2.4 | 2.6 |
Diluted EPS | 3.5 | — | 2.3 | 2.6 |
Basic average shares | 613.5M | — | 613.5M | 612.9M |
Diluted average shares | 617.0M | — | 618.7M | 617.7M |
EBITDA | 3.5B | 3.5B | 2.4B | 2.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | -4.5M | -4.2M | -2.6M | -2.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |